Tranzbyte Corporation (OTCPINK: ERBB) saw its share volume dip with 53,780,689 shares exchanging hands, significantly lower than its three month average daily volume of 147,924,573 shares.
Tranzbyte recently announces it will change its corporate name to American Green. The name change should take place sometime within the next several weeks and will be subject to review by FINRA and the stae of Nevada. The company’s stock symbol, ERBB, will remain the same and there will be no restructuring of the company’s share or management structure.
"Our name is changing to reflect the company's primary effort to maintain its leadership in the rapidly emerging Cannabis market. American Green has an opportunity to help guide both the growth and the narrative of this fast-expanding market, and to contribute to the education of the general public regarding the vast economic, medicinal, or adult-use benefits found in cannabis' many forms that are now available to Americans in over 20 states," says Tranzbyte COO Stephen Shearin.
Tranzbyte Corporation will be "pushed down" into the company structure as a subsidiary of American Green where it will continue its focus on selecting development stage companies for acquisition and possible spin-outs in the future. "Far from departing from our technology roots, Tranzbyte will remain as a division continuing to supply technological efficiencies for businesses everywhere, and, of course, remain focused in finding and acquiring companies that represent a great fit for our company," adds David Gwyther, Tranzbyte's president.
ERBB closed May 9th at $.03.
PennyPickAlerts.com is one of the most talked about stock newsletters in the world. To receive 100% FREE stock alerts that have incredible potential, sign up here:
United Cannabis Corporation (OTCQB: MYSK) saw its stock volume soar on May 9th with 99,693 shares exchanging hands, over three times higher than its three month daily average volume of 30,862 shares.
This uptick in volume comes after United Cannabis Corporation, formerly MySkin Inc., announced the appointment of Drs. Brent Reynolds and Dennis Steindler as Chief Medical Advisors to run and manage Discovery Research & Development for United Cannabis Corporation, who are focused on exploring the medical applications of cannabinoids.
"Based on the evidence and efficacy of our programs, we are building our foundation from human studies. Our team will seek out the science behind full spectrum cannabinoids to develop synergistic medicine to compliment conventional therapies. We have an opportunity that not only allows us to research the plant, but also convert those findings into realized products approved for medical application worldwide," says Vice President & A.C.T Now Director Tony Verzura.
MYSK closed at $3.46 on May 9th, 19.24% lower than its previous close of $4.2843.
Cannabis Science Inc. (OTCQB: CBIS) saw its share volume plummet on May 9th with 5,912,120 shares exchanging hands, significantly lower than its previous three month daily share volume of 14,550,705.
Cannabis Science Inc. recently announces its support for the Eighth National Clinical Conference on Cannabis Therapeutics sponsored by the not-for-profit Patients Out of Time in conjunction with the University Of California San Francisco School of Medicine (UCSF).
Patients Out of Time clinical cannabis educational series began in 2000. Through its conferences and on-going educational initiatives, the organization has become a leader in the field of medical cannabis education, helping patients and medical professionals understand why cannabis use continues to be a viable medical option for multiple conditions and diseases.
"As a company, we are committed to continuing and strengthening our support of Patients Out of Time in the years ahead. The organization's work is truly an inspiration to all of us who aim to increase the understanding of the efficacy of medical cannabis based on science," said Dorothy H. Bray, Ph.D., Director and CEO of Cannabis Science, Inc.
CBIS closed at $.0801 on May 9th, 6.8% higher than its previous close of $.075.
Interactive Health Network (OTCPINK: IGRW) saw its share volume skyrocket on May 9th with 13,685,060 shares exchanging hands, more than four times higher than its three month daily share volume of 3,850,933 shares.
This surge in volume comes after Interactive Health Network announced that The Green Baron interviewed Cesar D. Vazquez II, Executive VP of Interactive Health Network, for the progress of the company.
Interactive Health Network is a publicly traded holdings company that manufactures, markets and sells high quality lifestyle products and nutraceuticals; including its wholly owned subsidiary, Cannabis Health Group, which focuses on the medical marijuana and hemp market space. We plan on extending and deepening our product lines to include other progressive market segments through acquisitions. We operate under strict levels of quality and operate with the highest level of integrity in all of our businesses. Interactive Health Network is publically traded on the OTC market under the symbol IGRW.
IGRW closed at $.0598 on May 9th, 17.25% higher than its previous close of $.051.
Pennypickalerts.com issues momentum alerts on stocks that can provide gains to day traders.
Pennypickalerts.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more.
Pennypickalerts.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Pennypickalerts.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the Pennypickalerts.com newsletter and receiving alerts from a Pro-Active team of researchers. Pennypickalerts.com believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.pennypickalerts.com
Pennypickalerts.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always own due diligence with any potential investment.